Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral insulin immune effects in relatives at risk for type 1 diabetes
2016-001923-30Phase 2Completed
- Sponsor
- TrialNet Coordinating Center
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by TrialNet Coordinating Center. Primary endpoint: Change in immune function. Started Jun 2021; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-001923-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001923-30.